InMode (NASDAQ:INMD) Announces Earnings Results

InMode (NASDAQ:INMD) announced its earnings results on Wednesday. The healthcare company reported $0.35 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.35, FiscalAI reports. The firm had revenue of $95.59 million during the quarter, compared to analyst estimates of $93.70 million. InMode had a return on equity of 11.83% and a net margin of 20.69%.The business’s revenue was up .0% compared to the same quarter last year. During the same period last year, the firm posted $0.47 EPS.

InMode Stock Performance

Shares of INMD opened at $15.12 on Friday. InMode has a fifty-two week low of $12.72 and a fifty-two week high of $16.74. The business has a 50-day moving average of $14.49 and a 200 day moving average of $14.25. The firm has a market cap of $869.10 million, a P/E ratio of 12.29 and a beta of 1.89.

Wall Street Analysts Forecast Growth

Several equities analysts recently weighed in on INMD shares. Barclays set a $19.00 price target on shares of InMode and gave the company an “overweight” rating in a research report on Thursday, May 7th. Robert W. Baird dropped their target price on shares of InMode from $17.00 to $14.00 and set a “neutral” rating on the stock in a research note on Thursday, May 7th. One investment analyst has rated the stock with a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, InMode currently has an average rating of “Hold” and an average target price of $16.00.

Hedge Funds Weigh In On InMode

Several large investors have recently modified their holdings of the business. Quadrant Capital Group LLC grew its stake in InMode by 127.8% in the 4th quarter. Quadrant Capital Group LLC now owns 1,945 shares of the healthcare company’s stock valued at $29,000 after buying an additional 1,091 shares in the last quarter. Advisory Services Network LLC bought a new position in shares of InMode in the third quarter worth $37,000. Deutsche Bank AG grew its position in shares of InMode by 35.9% in the fourth quarter. Deutsche Bank AG now owns 3,927 shares of the healthcare company’s stock valued at $58,000 after purchasing an additional 1,037 shares in the last quarter. Parallel Advisors LLC grew its position in shares of InMode by 113.3% in the fourth quarter. Parallel Advisors LLC now owns 4,318 shares of the healthcare company’s stock valued at $63,000 after purchasing an additional 2,294 shares in the last quarter. Finally, Brooklyn Investment Group bought a new stake in shares of InMode during the 4th quarter valued at $154,000. Hedge funds and other institutional investors own 68.04% of the company’s stock.

InMode Company Profile

InMode Ltd. (NASDAQ:INMD) is a medical technology company headquartered in Israel that develops, manufactures and markets devices for aesthetic and medical treatments. The company specializes in energy-based technologies, primarily radiofrequency platforms, designed to deliver minimally-invasive and non-invasive procedures.

InMode’s product portfolio encompasses a range of modular systems targeting body contouring, facial rejuvenation, skin tightening and other cosmetic applications. Key offerings include devices built on proprietary radiofrequency and radiofrequency-assisted lipolysis, enabling physicians to perform treatments such as tissue coagulation, skin resurfacing and subdermal volumizing with reduced downtime.

The company distributes its technologies through direct sales operations and distribution partners, serving medical professionals across multiple geographies including North America, Europe, Asia Pacific and Latin America.